The ED/SBS and the MR IRB will merge into a new Minimal Risk Research IRB (MRR IRB) in June. This committee will review all minimal risk research, including educational studies (k-12, college and medical school), social and behavioral studies, and most minimal risk biomedical studies. Any study that requires FDA oversight or is done at the VA or with VA funding will be reviewed by the HSIRB, regardless of risk level. The membership of the committee will be drawn from the current ED/SBS and MR IRB committees. The committee will meet twice a month to ensure timely review of protocols. The first meeting of the MRR committee is scheduled for June 28th. A link to all meeting dates can be found on the IRB Meeting Dates page.